Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
JUPITER: Latanoprostene bunod long-term safety in Japanese patients
NCT01895972Phase 3Completed
- Sponsor
- Bausch + Lomb
- Start
- Jul 2013
- Primary completion
- Apr 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of latanoprostene bunod in open-angle glaucoma (OAG), ocular hypertension, sponsored by Bausch + Lomb. Started Jul 2013; status: completed.
02
Drugs
latanoprostene bunod
03
Conditions
open-angle glaucoma (OAG)ocular hypertension
Beyond the preview
Go deeper on NCT01895972.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01895972.